Neely Mozaffarian, M.D., Ph.D.
About Neely Mozaffarian, M.D., Ph.D.
Neely Mozaffarian is the Chief Medical Officer at Atomwise, known for her extensive experience in drug development and leadership roles in several top pharmaceutical companies.
Chief Medical Officer at Atomwise
Neely Mozaffarian joined Atomwise as the Chief Medical Officer in September 2023. In this role, Mozaffarian leads the company's drug development initiatives, focusing on leveraging Atomwise's AI-driven technologies to accelerate the discovery of new therapeutics. Atomwise is recognized for its innovative approach to drug development, which utilizes artificial intelligence to predict the binding of small molecules to proteins. Mozaffarian's extensive experience in the pharmaceutical industry is set to significantly contribute to Atomwise's mission of transforming drug discovery.
Former Chief Medical Officer at GentiBio
Before joining Atomwise, Neely Mozaffarian served as the Chief Medical Officer at GentiBio. During her tenure at GentiBio, Mozaffarian was responsible for overseeing the company's clinical strategy and development programs. GentiBio focuses on developing engineered T regulatory (Treg) cell therapies for autoimmune and autoinflammatory diseases. Her role encompassed driving clinical trials and regulatory strategies to advance GentiBio's therapeutic candidates.
Vice President in Immunology at Janssen Pharmaceuticals
Neely Mozaffarian held a significant leadership position at Janssen Pharmaceuticals as Vice President in Immunology. In this capacity, she played a key role in guiding the company's immunology portfolio, focusing on the development and implementation of clinical programs. Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is known for its strong focus on immunology, including treatments for conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis.
Professional Experience at Leading Pharmaceutical Companies
Neely Mozaffarian has a diverse background in the pharmaceutical industry, having held various roles at Ichnos Sciences, Gilead, Lilly, AbbVie, and Bristol Myers Squibb. Throughout her career, Mozaffarian has contributed to multiple facets of drug development, from early research and clinical trials to regulatory affairs and market approval. This breadth of experience across multiple prestigious companies highlights her expertise in the field of drug development and pharmaceutical research.
Education and Medical Training
Neely Mozaffarian earned her MD and PhD from the Albert Einstein College of Medicine in New York. She furthered her medical expertise with specialized training in Internal Medicine and Rheumatology at the University of Washington in Seattle. This robust educational and training background has provided Mozaffarian with a deep understanding of medical sciences and clinical practices, forming a strong foundation for her roles in the pharmaceutical industry.